Filing Details
- Accession Number:
- 0001209191-17-037922
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-05 18:05:13
- Reporting Period:
- 2017-06-01
- Filing Date:
- 2017-06-05
- Accepted Time:
- 2017-06-05 18:05:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197032 | F Ian Smith | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Cfo & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-06-01 | 37,383 | $45.11 | 163,621 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 18,124 | $48.74 | 181,745 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 23,789 | $37.86 | 205,534 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 9,062 | $51.75 | 214,596 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-06-01 | 10,195 | $38.80 | 224,791 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-01 | 98,553 | $124.00 | 126,238 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-06-01 | 37,383 | $0.00 | 37,383 | $45.11 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-06-01 | 18,124 | $0.00 | 18,124 | $48.74 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-06-01 | 23,789 | $0.00 | 23,789 | $37.86 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-06-01 | 9,062 | $0.00 | 9,062 | $51.75 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-06-01 | 10,195 | $0.00 | 10,195 | $38.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-02-04 | No | 4 | M | Direct | |
| 0 | 2022-07-24 | No | 4 | M | Direct | |
| 0 | 2022-02-01 | No | 4 | M | Direct | |
| 0 | 2021-07-12 | No | 4 | M | Direct | |
| 0 | 2021-02-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,306 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1.
- Fully vested.
Billionaire Hedge Funds
